Phuong N. Huynh

Array ( [id] => 1181469 [patent_doc_number] => 06737405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-18 [patent_title] => 'Stabilized protein preparation and process for its preparation' [patent_app_type] => B2 [patent_app_number] => 09/849343 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1455 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737405.pdf [firstpage_image] =>[orig_patent_app_number] => 09849343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1132560 [patent_doc_number] => 06783761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Chimeric peptide immunogens' [patent_app_type] => B2 [patent_app_number] => 09/848834 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7094 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783761.pdf [firstpage_image] =>[orig_patent_app_number] => 09848834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968018 [patent_doc_number] => 20020090646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Calcitonin-related molecules' [patent_app_type] => new [patent_app_number] => 09/847712 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14209 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090646.pdf [firstpage_image] =>[orig_patent_app_number] => 09847712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 432434 [patent_doc_number] => 07265208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-04 [patent_title] => 'Fusion molecules and treatment of IgE-mediated allergic diseases' [patent_app_type] => utility [patent_app_number] => 09/847208 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20328 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/265/07265208.pdf [firstpage_image] =>[orig_patent_app_number] => 09847208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778716 [patent_doc_number] => 20030049797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Hybrid proteins for autoimmune disease' [patent_app_type] => new [patent_app_number] => 09/836433 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9768 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049797.pdf [firstpage_image] =>[orig_patent_app_number] => 09836433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142450 [patent_doc_number] => 20020002277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Inhibitors of platelet activation and recruitment' [patent_app_type] => new [patent_app_number] => 09/835147 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26015 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002277.pdf [firstpage_image] =>[orig_patent_app_number] => 09835147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5967305 [patent_doc_number] => 20020090352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Compositions and methods for use in modulating immune system function' [patent_app_type] => new [patent_app_number] => 09/832922 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30285 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090352.pdf [firstpage_image] =>[orig_patent_app_number] => 09832922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1160344 [patent_doc_number] => 06759035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-06 [patent_title] => 'Method to prevent graft rejection using TGF-beta to induce T suppressor cells' [patent_app_type] => B2 [patent_app_number] => 09/833526 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 6666 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759035.pdf [firstpage_image] =>[orig_patent_app_number] => 09833526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7429473 [patent_doc_number] => 20040001826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Glycoprotein VI and uses thereof' [patent_app_type] => new [patent_app_number] => 09/829495 [patent_app_country] => US [patent_app_date] => 2001-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 72860 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001826.pdf [firstpage_image] =>[orig_patent_app_number] => 09829495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6157684 [patent_doc_number] => 20020146753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Autoantibodies to glucose-6-phosphate isomerase and their participation in autoimmune disease' [patent_app_type] => new [patent_app_number] => 09/828708 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24934 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146753.pdf [firstpage_image] =>[orig_patent_app_number] => 09828708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827944 [patent_doc_number] => 20020068062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Inhibitors of the formation of soluble human CD23' [patent_app_type] => new [patent_app_number] => 09/827406 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8622 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068062.pdf [firstpage_image] =>[orig_patent_app_number] => 09827406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711799 [patent_doc_number] => 20030171548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Proteins with a high immunoreactivity and a method for the production thereof' [patent_app_type] => new [patent_app_number] => 10/240912 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9039 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171548.pdf [firstpage_image] =>[orig_patent_app_number] => 10240912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 195520 [patent_doc_number] => 07635479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Composition and methods for enhancing immunogenecity of antigens' [patent_app_type] => utility [patent_app_number] => 10/239703 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4990 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635479.pdf [firstpage_image] =>[orig_patent_app_number] => 10239703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921652 [patent_doc_number] => 20020115103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use' [patent_app_type] => new [patent_app_number] => 09/816989 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11328 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115103.pdf [firstpage_image] =>[orig_patent_app_number] => 09816989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529477 [patent_doc_number] => 20020136695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Human medical treatment by aerosol inhalation of immunoglobulin A' [patent_app_type] => new [patent_app_number] => 09/815026 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3004 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136695.pdf [firstpage_image] =>[orig_patent_app_number] => 09815026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174447 [patent_doc_number] => 20020155110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them' [patent_app_type] => new [patent_app_number] => 09/811367 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12496 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20020155110.pdf [firstpage_image] =>[orig_patent_app_number] => 09811367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898790 [patent_doc_number] => 20010046955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Method for reducing allergen-induced airway hyperresponsiveness' [patent_app_type] => new [patent_app_number] => 09/809753 [patent_app_country] => US [patent_app_date] => 2001-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22892 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20010046955.pdf [firstpage_image] =>[orig_patent_app_number] => 09809753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935452 [patent_doc_number] => 20020061315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Modulation of allergic response' [patent_app_type] => new [patent_app_number] => 09/804464 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8818 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061315.pdf [firstpage_image] =>[orig_patent_app_number] => 09804464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6616599 [patent_doc_number] => 20020064820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-30 [patent_title] => 'Apo-A-I regulation of T-cell signaling' [patent_app_type] => new [patent_app_number] => 09/803918 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 37659 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20020064820.pdf [firstpage_image] =>[orig_patent_app_number] => 09803918 [rel_patent_id] =>[rel_patent_doc_number] =>)